-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deficit-hyperactivity.pdf
January 01, 2019 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in
Children and Adolescents
Background
The Patient-Centered Outcomes Research Institute (PCORI) is partnering with AHRQ to update
a systematic evi…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity.pdf
January 01, 2019 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in
Children and Adolescents
Background
The Patient-Centered Outcomes Research Institute (PCORI) is partnering with AHRQ to update
a systematic evi…
-
www.ahrq.gov/research/findings/studies/index.html?page=180
January 01, 2024 - AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results 4501 to 4525 of 12077 Research Studies Displayed
Pagination
« first
« First
‹ previous
‹‹
…
-
www.ahrq.gov/research/findings/factsheets/children/publications/2010.html
October 01, 2014 - Aortic dissection in young adults who abuse amphetamines. Am Heart J 2010 Aug; 160(2):315-21.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
December 23, 2015 - Untitled
Source: www.effectivehealthcare.ahrq.gov
Published online: December 23, 2015
Evidence-based Practice Center Systematic Review Protocol
Project Title: Suicide Prevention
I. Background and Objectives for the Systematic Review
Despite advances in the diagnosis and treatment of major mental disord…
-
effectivehealthcare.ahrq.gov/products/suicide-prevention/research-protocol
December 28, 2015 - Current Page Topic Timeline Sep. 18, 2015 Topic Initiated Dec. 28, 2015 Research Protocol Oct. 4, 2016 Systematic Review Feb. 9, 2017 Disposition of Comments Report Suicide Prevention
Research Protocol Archived December 28, 2015 Download Main Document PDF 1.3 MB
Archived: This report is greater than …
-
www.ahrq.gov/news/newsroom/case-studies/index.html?page=39
June 01, 2007 - Impact Case Studies
AHRQ’s evidence-based tools and resources are used by organizations nationwide to improve the quality, safety, effectiveness, and efficiency of health care. The Agency’s Impact Case Studies highlight these successes, describing the use and impact of AHRQ-funded tools by State and Federal policy ma…
-
hcup-us.ahrq.gov/reports/statbriefs/sb249-appendix.pdf
March 18, 2019 - encounter
T43605A Adverse effect of unspecified psychostimulants, initial encounter
T43621A Poisoning by amphetamines … , accidental (unintentional), initial encounter
T43623A Poisoning by amphetamines, assault, initial … encounter
T43624A Poisoning by amphetamines, undetermined, initial encounter
T43625A Adverse effect … of amphetamines, initial encounter
T43631A Poisoning by methylphenidate, accidental (unintentional) … encounter
T43612A Poisoning by caffeine, intentional self-harm, initial encounter
T43622A Poisoning by amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
August 01, 2016 - Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence
Psychosocial and Pharmacologic Interventions for Disruptive Behavior
Disorders in Children and Adolescents: Current State of the Evidence
Focus of This Summary
This is a summar…
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
August 31, 2016 - Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence
Clinician Summary Archived August 31, 2016 Download Main Document PDF 258.3 KB
Archived: This report is greater than 3 years old. Findings may be used for research p…
-
www.ahrq.gov/research/findings/studies/index.html?page=269
January 01, 2024 - AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results 6726 to 6750 of 12077 Research Studies Displayed
Pagination
« first
« First
‹ previous
‹‹
…
-
hcup-us.ahrq.gov/tech_assist/data_query/Methods_Community_Statistics20230207.pdf
December 01, 2022 - barbiturates, benzodiazepines, sedatives, prescription
opioids, dextromethorphan, pseudoephedrine, amphetamines
-
hcupnet.ahrq.gov/downloadables/508_Methods_Community-Statistics-1-28-21-Edited.pdf
January 01, 2021 - barbiturates, benzodiazepines, sedatives, prescription opioids, dextromethorphan,
pseudoephedrine, amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
October 01, 2011 - 1991 to 1999, prescriptions
for MPH increased from 4 million to 11 million, and
prescriptions for amphetamines
-
hcup-us.ahrq.gov/tech_assist/data_query/508_Methods_Community_Statistics20220128.pdf
January 01, 2021 - barbiturates, benzodiazepines, sedatives, prescription opioids, dextromethorphan,
pseudoephedrine, amphetamines
-
cahps.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
monahrq.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
talkingquality.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
ahrqpubs.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
patientregistry.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines